Astrazeneca Plc Adr Stock Analysis

AstraZeneca Stock Analysis Notes

About 18.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.07. AstraZeneca PLC ADR last dividend was issued on the 21st of February 2025. The entity had 2:1 split on the 27th of July 2015. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 83100 people. For more info on AstraZeneca PLC ADR please contact Pascal Soriot at 44 20 3749 5000 or go to https://www.astrazeneca.com.

AstraZeneca PLC ADR Investment Alerts

AstraZeneca PLC ADR Upcoming and Recent Events

AstraZeneca Largest EPS Surprises

View All Earnings Estimates

AstraZeneca PLC Environmental, Social, and Governance (ESG) Scores

AstraZeneca PLC Thematic Classifications

AstraZeneca Stock Institutional Investors

Note, although AstraZeneca PLC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

AstraZeneca Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 238.07 B.

AstraZeneca Profitablity

The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.23 %, which entails that for every 100 dollars of revenue, it generated $0.23 of operating income.

Management Efficiency

AstraZeneca PLC ADR has Return on Asset of 0.0788 % which means that on every $100 spent on assets, it made $0.0788 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1759 %, implying that it generated $0.1759 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. At this time, AstraZeneca PLC's Return On Capital Employed is very stable compared to the past year. As of the 24th of March 2025, Return On Assets is likely to grow to 0.10, while Return On Tangible Assets are likely to drop 0.11. At this time, AstraZeneca PLC's Intangibles To Total Assets are very stable compared to the past year. As of the 24th of March 2025, Return On Assets is likely to grow to 0.10, while Total Current Assets are likely to drop about 15.7 B.

Technical Drivers

As of the 24th of March, AstraZeneca PLC shows the Mean Deviation of 0.9694, downside deviation of 1.29, and Risk Adjusted Performance of 0.1522. AstraZeneca PLC ADR technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

AstraZeneca PLC ADR Price Movement Analysis

AstraZeneca PLC Outstanding Bonds

AstraZeneca PLC Predictive Daily Indicators

AstraZeneca PLC Corporate Filings

AstraZeneca PLC Forecast Models

AstraZeneca PLC's time-series forecasting models are one of many AstraZeneca PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AstraZeneca PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how AstraZeneca PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AstraZeneca shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AstraZeneca PLC. By using and applying AstraZeneca Stock analysis, traders can create a robust methodology for identifying AstraZeneca entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AstraZeneca analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AstraZeneca analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

AstraZeneca PLC ADR stock analysis indicators help investors evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By understating and applying AstraZeneca PLC stock analysis, traders can identify AstraZeneca PLC position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.